-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Phio Pharmaceuticals Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Phio Pharmaceuticals Corp. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.85M, a 27.6% increase year-over-year.
- Phio Pharmaceuticals Corp. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$8.68M, a 30.4% increase year-over-year.
- Phio Pharmaceuticals Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.8M, a 5.7% increase from 2022.
- Phio Pharmaceuticals Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.5M, a 13.6% increase from 2021.
- Phio Pharmaceuticals Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.3M, a 51.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)